Speaker Profile
Ph.D., VP, Multiomics, Innovation and Scientific Affairs, BD Biosciences
Biography
Aruna Ayer is the VP, Multiomics, Innovation Scientific Affairs at BD Biosciences. She leads a multidisciplinary team responsible for an exciting portfolio of next-generation single-cell solutions including instruments, multiomic assays, reagents and informatic solutions. Her team is also responsible for managing external scientific partnerships and collaborations supporting product development and product adoption. Aruna holds a Ph.D. in Cellular and Molecular Biology from the University of Texas, Austin and bachelors in biotechnology from Anna University, India. Aruna joined BD Biosciences from Roche Sequencing Solutions, where she held various roles of increasing leadership responsibility for 7 years developing the Roche Nanopore Sequencing Technology. Aruna is a named inventor on multiple patents and has published in multiple high-impact scientific journals.
Talk
Precision Cell Profiling: Imaging, Spectral Flow Multiomics Insights
Cellular analysis is a cornerstone of discovery in immuno-oncology and drug development. Herein, we present technologies and applications that showcase high-dimensional characterization of cells, with real-time image-based spectral sorting and multiomic single-cell profiling. This demonstrates the power of combining phenotypic and molecular data to accelerate translational and clinical research.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony Honoree
• W.E. Moerner, Stanford – Nobel Laureate
• Priscilla Chan, Co-Founder & Co-CEO, Chan Zuckerberg Initiative
• Serge Saxonov, 10x Genomics
Fireside Chat
• Moderator: Christina Curtis, Stanford
• W.E. Moerner, Stanford
• Priscilla Chan, Chan Zuckerberg Initiative
Fireside Chat with Serge Saxonov, 10x Genomics
Unraveling Tissue Architecture with Single-Cell & Spatial Multi-Omics
• Joakim Lundeberg, SciLifeLab
• Garry P. Nolan, Stanford
• Tae Hyun Hwang, Vanderbilt University Medical Center
Tumor Evolution & Clonal Dynamics: From Models to Monitoring
• Chair: Christina Curtis, Stanford
Multi-Omics-Driven Early Detection: Beyond Liquid Biopsy
• Ash Alizadeh, Stanford
• Alex Aravanis, Moonwalk Biosciences
Personal Omics at Scale: What Longitudinal Profiles Add to Early Detection
• Michael Snyder, Stanford
AI in Molecular Diagnostics: Integrating Multi-Omics & Clinical Data
• Chair: Marina Sirota, UCSF
• Olivier Gevaert, Stanford
• Rebecca Critchley-Thorne, Castle Biosciences
Nanomechanical Signatures for Cancer Diagnostics: Insights from Tumor Biophysics
• Chair: Marija Plodinec, Artidis
